| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Feb 2025 | 24 Jan 2025 |
| Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company will be held on Thursday 06 February 2025 to consider and approve inter alia the following: 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2024 Further pursuant to Companys Code of Conduct for prohibition of Insider Trading the trading window for transacting in the securities of the company was closed from 01 January 2025 and will remain closed till 08 February 2025 for the Directors / officials and designated persons of the Company Pursuant to Regulation 30, 33 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of Directors of the Company, at its meeting held on Thursday, 06 February 2025, inter-alia considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company and noted the Limited Review Reports of the Statutory Auditors, M/s. Deloitte Haskins & Sells LLP for the quarter and nine months ended 31 December 2024. A copy of the same are enclosed herewith as Annexure. The Meeting of the Board of Directors was duly commenced at 6.30 PM (IST) and concluded at 9.15 PM (IST). (As Per Bse Announcement Dated on 06.02.2025) | ||
The IPO that was opened between December 11 and December 13, 2024 aggregates to ₹3,042.62 crore and has had a price band of ₹533-549 per equity share.
Investors can bid for up to 27 shares in a single lot, with the company setting a price range of Rs 522-549 per share.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
